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The impact of certain estrogenic xenobi-
otics on the development, health, and
reproductive systems of wildlife has been
clearly documented (1). As data accumu-
late, environmental xenobiotics are also
being implicated in human infertility, geni-
tal tract malformations, and increased can-
cer rates in estrogen target tissues (2,3). In
1936, Dodds and Lawson reported the
estrogenicity of some diphenyl compounds
containing two hydroxyl groups in para
positions (4). Reid and Wilson (5) subse-
quently confirmed the estrogenicity of 4,4'-
dihyroxydiphenylmethane derivatives. One
such derivative, bearing two methyl groups
and known as bisphenol-A, is a major com-
ponent of epoxy resins. Bisphenol-A was
found to leach from autoclavable polycar-
bonate laboratory flasks (6). Recently, we
demonstrated that food packed in lacquer-
coated cans was active in a bioassay for
estrogenicity; bisphenol-A released from the
epoxy resin lining ofthe cans was identified
as the estrogenic contaminant (7).
Bisphenol-A is a common ingredient in
restorative materials used in dentistry. Since
the 1960s, when bisphenol-A diglycidyl
methacrylate (bis-GMA)-based restorative
materials were first used in odontology,
many studies have assessed the effects of
resins on pulpal injury (8) and their cyto-
toxic properties (9-11). Little attention was
paid, however, to the systemic health effects
of these chemicals or their monomers
(12,13). Some studies focused on the alky-
lating properties of the glycidaldehyde por-
tion of bisphenol-A diglycidylether
(BADGE)(14). For example, the formation
of glycidaldehyde adducts in adenine
residues was demonstrated in mice after
cutaneous treatment with BADGE (15).
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Other studies examined the mutagenic an
carcinogenic properties of epoxy resi
monomers, with contradictory results (15,
Resin-based composite restoratih
materials used in dentistry ("composites'
consist of two major components: a
organic resin matrix and an inorganic fille
Composites without inorganic fillers a.
known as "sealants." Tooth-colore
restorative materials are increasingly use
for preventive purposes, to replace missir
tooth structures and to modify tooth cob
and contour. The resin matrix is initial
present as a fluid monomer that is conver
ed into a rigid polymer by a free radica
initiated reaction of addition. The pot
merization reaction (curing) can be chenm
cally initiated (autocuring) or photoinitia
ed using ultraviolet or visible light in tI
presence ofaphotoinitiator.
Because of the low degree ofpolyme.
ization required by the monomers in con
posites, concerns have been expresse
about the leaching of chemicals froi
unpolymerized material, which is rapid'
released after curing (16). In vitro studii
have shown that most of the unpolyme
ized monomers of bis-GMA had leache
24 hr afterserting. In addition, cured con
posites placed in the oral cavity ai
attacked mechanically and chemicall,
Enzymatic hydrolysis of methacrylate
together with mechanical forces, coi
tribute to the breakdown of composii
resins (17), which are slowly and persi
tentlydegraded (11]).
A significant portion ofthe uncured
decomposed material that is swallowed co
be absorbed by the intestine. Climie et
(19,20) studied the metabolic degradatic
of 14C-BADGE in mice after the or
administration of a single dose and found
that 90% of the radioactivity was eliminat-
ed in feces and urine during the first 3 days
of the experiment. Interestingly, a small
k amount of BADGE (- 5%) underwent
F oxidative dealkylation to yield glycidalde-
hyde (which has alkylating properties) and
V bisphenol-A, among other by-products
(20). The systemic behavior ofthe dipheno-
lic derivative is poorly known and needs
further investigation.
The purpose of this research was to
determine whether bis-GMA-based restora-
tive resins and their components have estro-
Ld genic activity in an in culture assay. We
in demonstrate here that the sealant and resin
). components bisphenol-A and bisphenol-A
ve dimethacrylate are estrogenic and may rep-
1)) resent an additional source of xenoestrogen
In exposure in humans.
,r.
re Methods
d Cell line and culture conditions. MCF7
Id human breast cancer cells originally estab-
ig lished by Soule and colleagues (21) were at
or passages 100-106 postcloning at the time
ly of study. For routine maintenance, cells rt- were grown in Dulbecco's modification of 1- Eagle's medium (DME) supplemented with
y- 5% fetal bovine serum (FBS; PAA Labor
li- und Forschungs Ges, MBH, Linz, Austria)
Lt- in an atmosphere of5% C02/95% air under he saturating humidity at 37°C.
Plasma-derived human serum and
r- removal ofsex steroids. Plasma-derived
n- human serum was prepared from expired
4d plasma by adding calcium chloride to a final
m concentration of 30 mM to facilitate clot
[ly formation. We removed sex steroids from
es serum by charcoal-dextran stripping (22).
r- Briefly, a suspension of 5% charcoal (Norit
n-
re
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A, Sigma Chemical Co., St. Louis,
Missouri) with 0.5% dextran T-70
(Pharmacia-LKB, Uppsala, Sweden) was
prepared. Aliquots of the charcoal-dextran
suspension ofavolume similar to the serum
aliquot to be processed were centrifuged at
1iOOg for 10 min. Supernatants were aspi-
rated, and serum aliquots were mixed with
the charcoal pellets. This charcoal-serum
mixture was maintained in suspension by
rolling at 6 cycles/min at 37°C for 1 hr.
The suspension was centrifuged at 10OOg
for 20 min, and the supernatant was then
filtered through a 0.20-pm filter (Gelman
Sciences, Ann Arbor, Michigan). Charcoal
dextran-treated human serum (CDHuS)
was stored at -20°C until needed.
Cellproliferation experiments. We used
MCF7 cells in the E-screen test of estro-
genicity according to a technique slightly
modified (23) from that originally
described by Soto et al. (24). Briefly, cells
were trypsinized and plated in 24-well
plates (Limbro, McLean, Virginia) at initial
concentrations of 10,000 cells per well in
5% FBS in DME. Cells were allowed to
attach for 24 hr, then the seeding medium
was replaced with 10% CDHuS-supple-
mented phenol red-free DME. Different
concentrations of the test compound were
added, and the assay was stopped after 144
hr by removing medium from wells, fixing
the cells, and staining them with sulforho-
damine-B (SRB). The staining technique
was modified from that described by
Skehan et al. (25). Briefly, cells were treated
with cold 10% trichloracetic acid and incu-
bated at 4°C for 30 min, washed five times
with tap water, and left to dry.
Trichloroacetic-fixed cells were stained for
10 min with 0.4% (wt:vol) SRB dissolved
in 1% acetic acid. Wells were rinsed with
1% acetic acid and air dried. Bound dye
was solubilized with 10 mM Tris base (pH
10.5) in a shaker for 20 min. Finally,
aliquots were transferred to a 96-well plate
and read in a Titertek Multiscan apparatus
(Flow, Irvine, California) at 492 nm. We
verified the linearity of the SRB assay by
cell numberbefore cellgrowth experiments.
Results are expressed as means ± SDs.
We normalized mean cell numbers from
each experiment to the steroid-free control
cultures to correct for differences in the ini-
tial seeding density. Differences between
the xenoestrogen and estradiol-17L; groups
were assessed by analysis of variance and
the aposteriori Scheffe's test. A p -value <
0.05 was regarded as significant.
Estrogen andprogesterone receptormea-
surements. MCF7 cells were seeded in T-
25 flasks in 5% FBS-supplemented DME.
On the following day, the medium was
changed to 10% CDHuS-supplemented
phenol red-free DME medium, and estradi-
ol-17l3 or the chemicals to be tested were
added. One group of cells received vehicle
alone. After 72 hr, the culture medium was
discarded and cells were frozen in liquid
N2. To extract receptor molecules, we incu-
bated cells at 40C for 30 min with 1 ml
extraction buffer (0.5 M KCl, 10 mM
potassium phosphate, 1.5 mM EDTA, and
1 mM monothioglycerol, pH 7.4), accord-
ing to a technique previously described in
detail (26). After centrifugation to pellet the
cell debris, estrogen and progesterone recep-
tors were measured in a 100-jil aliquot of
the supernatant by enzyme immunoassay
using the Abbott ER and PgR enzyme
immunoassay monoclonal kits (Abbott
Diagnostic, Wiesbaden, Germany) accord-
ing to the manufacturer's instructions.
Estrogen-induced cell type-specific pro-
teins. We measured cathepsin-D and pS2
in the culture medium ofMCF7 cells with
the ELSA-CATH-D and ELSA-PS2
immunoradiometric assays (CIS Bio
International, Gif-sur-Yvette, France). The
culture medium was centrifuged at 1,200g
for 10 min to eliminate floating and
detached cells. Samples were kept frozen at
-800C until the assays were conducted.
Competitive binding assays. Cytosol
from immature, female rat uteri was pre-
pared at a protein concentration ofapprox-
imately 2 mg/ml in phosphate buffer.
Aliquots ofthis 105,000gsupernatant were
then incubated with various concentrations
of bisphenol-A, bisphenol-A dimethacry-
late, BADGE, bis-GMA, and 3 nM
[3H]estradiol for 16 hr at 0-40C. The free
and bound fractions were separated with
the charcoal-dextran technique. We calcu-
lated the relative binding ability (RBA) of
each competitor as the ratio ofthe concen-
tration of radioinert estradiol/competitor
required to inhibit 50% of the specific
[3H]estradiol binding, with the affinity of
estradiol set at 100%.
Determination ofcomponents in resin-
based restorative material We analyzed
four commercial bis-GMA-based compos-
ite resins using an HPLC technique.
Aliquots of 50-100 mg of each sample
were suspended in 1 ml ethanol and chro-
matographed using a Lichrocart Merck S5
ODS column (20 x 0.4 cm; Merck,
Darmstadt, Germany) at a flow rate of 1
ml/min in a Perkin-Elmer 250 binary LC
chromatograph with a Perkin-Elmer 235
diode array detector 235 equiped with a
20-pl loop injector (Waters 717 Plus
Autosampler). The gradient was: at time =
0 min, 100% phase A (acetonitrile-water,
1:1) and 0% phase B (acetonitrile); at time
= 15 min, 100% phase B and 0% phase A;
and at time = 17 min, 100% phase A and
0% phase B. The elution profile was moni-
tored at 280 and 254 nm.
Determination ofbisphenol-A and
relatedcompounds in saliva. For the dini-
cal study, 18 healthy men and women (age
range 18-25 years, mean age 20 years) were
treated. The experiment was conducted in
accordance with the Helsinki Declaration.
A sealant was applied to 12 molars accord-
ing to a standard technique that included
visible light as the activator of the curing
agents. Samples ofwhole salivawere collect-
ed by having subjects spit for 1 hr before
and 1 hr after treatment into preweighed
glass flasks containing 10 ml ethanol. The
amount of commercial bis-GMA-based
sealant used was approximately 50 mg per
subject. After collection, saliva samples were
centrifuged (1OOOg, 10 min) and passed
through a 0.45-pm pore filter. Aliquots of
20 pl were chromatographed by HPLC as
described above and by GC/MS. Saliva
samples were also tested for estrogenicity in
the MCF7 breast cancer assay.
Spectroscopy. Mass spectra ofextracted
composite resins, filtered saliva samples,
and technical grade bisphenol-A,
dimethacrylate of bisphenol-A, and
BADGE were obtained in a mass spec-
trometry system (Fisson VG Platform-II,
Manchester, UK) operating at an ion
source temperature of 200°C in a Fisson
GC 8000 SM Autospec chromatograph
(Milan, Italy). A 15-m methyl silicon col-
umn (OV-P) was used at a flow rate of 1.2
ml/min, with helium as the carrier gas. The
oven temperature was 80-320°C, with a
graded increase of 10°C/min. Relative
retention times ofall the components ana-
lyzed were 16.2 min for bisphenol-A; 20.5
min for BADGE, and 21.2 min for bisphe-
nol-Adimethacrylate.
Steroids andchemicalcompounds tested
Estradiol-17g was obtained from Sigma.
Bisphenol-A, bisphenol-A dimeth-acrylate,
BADGE, and bis-GMA were obtained
from Aldrich (Aldrich-Chemie, Albuch,
Germany). Chemicals were dissolved in
ethanol to a final concentration of 1 mM
and stored at -20°C.
The resin based-materials we tested were
Tetric (Ivoclar-Vivadent, Schaan, Liechten-
stein), Charisma (Kulzer, Wehrheim,
Germany), Pekalux (Bayer, Germany),
identified as composites 1,2 and 3, respec-
tively, and two different batches of the
sealant Delton (Ash/Dentsply, Konstanz,
Germany). All were diluted in phenol red-
free DME immediately before use in the
culture assay. The final ethanol concentra-
tion in the culture medium did not exceed
0.1%. We obtained [2,4,6,7-3H]estradiol
(103 Bq/mmol) from Amersham
(Buckinghamshire, England).
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Results
EstrogenicActivity ofResin-based
Composites
The addition of estradiol-17g to CDHuS-
supplemented medium increased the num-
bers of MCF7 cells in culture. Maximum
proliferative effect was obtained at estradi-
ol-17f concentrations of 10 pM and higher
(Fig. IA). Cell yields were sixfold greater
than in control cultures after 6 days (mean
± SD, 6.67 ± 1.21; n = 15 experiments). In
the absence of estradiol-17l3, cells prolifer-
ated minimally.
Four bis-GMA-based composite resins
were assayed before polymerization using
the MCF7 proliferation test. Composites
and sealants were prepared in ethanol at a
concentration of 100 and 50 mg/ml,
respectively, and assayed at a range ofdilu-
tions (1/100 to 1/106). The cell yield
obtained with 5 pg/ml sealant sample was
sixfold greater than in control cultures. The
magnitude of this proliferative effect was
similar to that obtained with estradiol-1713.
Cell toxicity was observed at concentra-
tions of50 pg/ml and higher (Fig. 1B).
In contrast to the sealant sample, the
three resin-based composites assayed did
not induce MCF7 cell proliferation at a
maximal concentration of 1 mg/ml. These
commercial formulations contain a large
proportion of inorganic filler particles
(50-85% by weight of the composite).
Stock suspensions were prepared without
discarding the inorganic portion.
0
U
;
0
0
LI.
Identification ofEstrogenic
Substances from Composite Resins
Figure 2 shows the HPLC profile of an
unpolymerized sealant that was positive in
the proliferation test. Relative retention
times ofthe components identified were: t=
2.35 min or bisphenol-A; t = 7.35 min for
BADGE; t= 8.55 min for bis-GMA; and t =
11.85 min for dimethacrylate ofbisphenol-
A. These components were quantified by
calibration curves made after eluting known
amounts (1 liM to 1 mM) ofthe pure sub-
stance [bisphenol-A, y = (2.92 x 1011)x +
(9.075 x 106), r = 0.998; bis-GMA, y =
(1.04 x 1011)x + (0.670 x 106), r = 0.999;
BADGE, y = (1.12 x 1011)x + (0.470 x
106), r = 0.999, and bisphenol-A
dimethacrylate, y = (2.18 x 10'1)x + (8.782
x106), r= 0.995]. Mass spectrometric analy-
sis confirmed the presence of bisphenol-A
and dimethacrylate of bisphenol-A in all
samples for which HPLC chromatograms
showed thecorresponding peaks (Fig. 3).
To determine whether the monomer
bisphenol-A can be cleaved from compos-
ites and from their main oligomers
(dimethacrylate of bisphenol-A, bis-GMA,
and BADGE), these were hydrolyzed in
alkaline (pH = 13) and acidic media (pH =
1) after heating (100'C for 30 min), and
then chromatographed as indicated. Table
1 summarizes the components identified in
the chromatograms. Extensive breakdown
of the oligomers into smaller compounds
such as bisphenol-A was observed.
I 0
-
S a0
b0
10 aL
1013 1o-ll
Concentration (M)
EstrogenicActivity ofSome
Components ofResin-based
Restorative Composites
Bisphenol-A and its dimethacrylate were
estrogenic when assayed in the breast can-
cer cell proliferation assay. The concentra-
tions required to produce maximum prolif-
eration of MCF7 cells were 10,000-fold
higher than those ofestradiol-17f; (Fig. 4).
MCF7 cells were grown in the presence of
bisphenol-A or bisphenol-A dimethacrylate
and the estrogen antagonist hydroxytamox-
ifen; the proliferative effect of 0.1 pM
bisphenol-A and bisphenol-A dimethacry-
late disappeared when cells were grown in
the presence ofa 10-fold higher concentra-
tion ofthe antagonist (data not shown).
Bis-GMA was negative in the estro-
genicity test. A proliferative effect of
BADGE was observed at a concentration
of 10 pM (Fig. 5). Oligomers from both
compounds became active in the prolifera-
tive test after hydrolysis (100°C for 30
min, in alkaline or acidic medium).
Bisphenol-A and bisphenol-A dimethacry-
late were identified in chromatograms
when oligomers were found to be estro-
genic after hydrolysis.
Progesterone Receptor Induction
MCF7 cells have receptors for estradiol-
17f (estrogen receptor; ER) and proges-
terone (PgR). The basal concentration of
3
0.05 0.5 5 50 500
Concentration(gg/ml)
Figure 1. Cell proliferation of MCF7 cells. Cells growing in 10% charcoal dextran-treated human serum-
supplemented medium were exposed for 144 hr to (A) estradiol-17B and (B) bis-GMA-based sealant,
sample no. 1. Points represent quadruplicate cultures; brackets indicate SDs. Ordinates represent cell
numbers (experimental/control); abscissas represent concentration ofthe test compound. Estradiol-171
was effective at>1 pM (0.272 pg/ml). *Values significantly differentfrom control, p< 0.001.
Figure 2. Chromatogram of sealant sample no. 1,
which was estrogenic in the breast cancer prolif-
eration bioassay shown in Figure 1. Peaks at
retention times 2.3, 7.3, 8.6, and 11.9 min were
identified as 1) bisphenol-A, 2) bis-GMA, 3)
BADGE, and 4) bisphenol-A dimethacrylate.
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ER in these cells was 183 ± 29 fmol/mg of
extracted protein (Fig. 6A). Estradiol-171
decreased the concentration ofER by 50%
and increased that of PgR The basal PgR
value was 15.5 ± 4.3 fmol/mg protein,
close to the lower limit ofdetection ofthe
monoclonal antibody assay (Fig. 6B).
Estradiol-17l (1 nM) significantly
increased PgR nearly 15-fold over the con-
trol value.
Treatment ofMCF7 cells with concen-
trations of 0.1 pM and higher of bisphe-
nol-A dimethacrylate resulted in a signifi-
cant increase in PgR levels. Bisphenol-A
treatment also increased PgR levels (Fig.
6B). However, no reduction of ER levels
was observed when bisphenol-A or bisphe-
nol-A dimethacrylate induced PgR
Secretion ofpS2 and Cathepsin-D
Cathepsin-D and pS2 accumulation in the
culture medium reflected increases in cell
number during the experiments. The secre-
tion ofpS2 by MCF7 cells was significant-
ly increased by >0.1 nM estradiol-17g (-
3.5-fold increase over controls). The basal
concentration of pS2 (55.4 ± 15.2 ngIl6
cells) increased to 202.2 ± 19.1 ng/10 cells
after treatment with 10 pM bisphenol-A
dimethacrylate; this was similar to the
effect of estradiol- 17L on pS2 secretion
(Fig. 7A).
The basal concentration ofcathepsin-D
secreted by MCF7 cells was 8.9 ± 2.9
pmol/106 cells. Estradiol-1781 treatment (1
and 10 nM) resulted in a modest 1.7-fold
increase in the accumulation ofcathepsin-
D in the culture medium. Bisphenol-A
dimethacrylate (1 and 10 pM) increased
cathepsin-D secretion only 1.6-fold (Fig.
7B). These changes were not significant.
BindingAffinityofComposite Resin
Compounds for the Estrogen
Receptor
The binding affinity of bisphenol-A,
bisphenol-A dimethacrylate, BADGE, and
bis-GMA for the cytosol ER was deter-
mined by competitive binding analysis.
The receptor relative binding affinities
(RBA) were 0.012 and 0.0033 for bisphe-
nol-A and bisphenol-A dimethacrylate,
respectively, versus 100 for estradiol-1711.
Bis-GMA and BADGE did not compete
with estradiol for binding to the ER, even
at concentrations a million-fold higher
thanestradiol-17f (Fig. 8).
Analysis and Quantification of
Estrogenic Substances in Saliva
Eighteen saliva samples taken before and
after sealant treatment were chromato-
graphed using the technique described in
Methods. Figure 9 shows the chromato-
100
100 r
50
0D U 70 W0 90 IlUU IIU 120 130 1IW IU 1W 17U 1WU 190 200 21U 22U 2d3 240 2W
Figure3. Mass spectra of(A) pure grade bisphenol-A and (B) bisphenol-Afrom a sealantsample.
Table 1. Identification ofthe components inthe composites and sealants"
pg/100 mg commercial product
Product Bisphenol-A
and pH Bis-GMA BADGE dimethacrylate Bisphenol-A
Sealant 1
7 45.8 75.0 29.2 7.4
13 32.8 117.0 4.6 84.4
1 49.4 164.8 6.4 18.2
Composite 1
7 105.0 19.6 ND 67.7
13 16.7 1.7 186.0 53.1
1 0.4 ND 1.8 49.9
Composite 2
7 18.1 10.0 ND 0.5
13 53.2 24.2 878.4 ND
1 46.8 140.0 ND ND
Composite 3
7 22.0 3.2 ND 4.2
13 1809.4 38.6 ND N D
1 1802.0 5.2 3.6 11.4
Abbreviations: bis-GMA, bisphenol-A digicidylether methacrylate; BADGE, bisphenol-A diglcidylether; ND,
notdetectable.
8Samples were hydrolyzed in alkaline (pH = 13) and acidic media (pH = 1) after heating (100'C for 30 min)
andthen chromatographed as indicated in Methods. The contents before hydrolysis are indicated as pH = 7.
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Figure 4. Cell proliferation in MCF7 cells. Cells 'growing in 10% charcoal dextran-treated human serum-
supplemented medium were exposed for 144 hr to (A) bisphenol-A and (B) bisphenol-A dimethacrylate.
Points represent quadruplicate cultures; brackets indicate SDs. *Values significantly different from con-
trol, p< 0.001.
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Figure 5. Cell proliferation in MCF7 cells. Cells growing in 10% charcoal dextran-treated human serum-
supplemented medium were exposed for 144 hr to (A) bis-GMA and (B) BADGE and to products obtained
by hydrolytic treatments ofthese compounds in alkaline (pH = 13) and acidic medium (pH = 1). Points rep-
resent quadruplicate cultures; brackets indicate SDs. *Values significantly different from control, p <
0.001.
graphic profile of a representative saliva
sample from a patient selected at random
after treatment with 50 mg of the bis-
GMA-based sealant. Peaks in the chro-
matogram corresponded to Bis-GMA,
BADGE, bisphenol-A, and dimethacrylate
of bisphenol-A. Variations in the chro-
matographic profiles were seen between
sealant batches and between patients who
received sealant from the same batch.
Monomers ofcomposite components were
measured by HPLC in saliva collected 1 hr
after treatment (Table 2). After treatment,
all saliva samples contained variable
amounts of bisphenol-A ranging from 90
to 931 pg; this was confirmed by mass
spectrometry.
Subjects were treated with a fixed
amount ofapproximately 50 mg ofsealant,
and the proportion offree, unpolymerized
material collected during 1 hr after treat-
ment never exceeded 2% of the total
_ 200
0
i E ,=oo 15(
101
5(
251
'I'S 201 0
*0.
CD
E 151
i -
nM gM gM
Concentration
1 10 1 10 1 10
nM gM gtM
Concentration
Figure 6. (A) Estrogen (ER) and (B) progesterone
(PgR) receptors in MCF7 cells. Cells in T25 flasks
were incubated in 10% charcoal dextran-treated
human serum for 72 hr with 1 and 10 nM of estra-
diol-17B. A parallel set of flasks was exposed to 1
and 10 pM bisphenol-A or bisphenol-A
dimethacrylate. Controls received the vehicle
alone. At the end of the experiment, the medium
was aspirated and flasks were kept in liquid N2
until assayed. ER and PgR were measured in
extracted cells with a monoclonal antibody tech-
nique as indicated in Methods. Results are
expressed as femtomole per milligram of extract-
ed protein ± SD. *Values significantly different
from control, p<0.001.
amount of sealant applied. Composite
components were not observed in any of
the saliva samples collected before treat-
ment. A subject initially selected for treat-
ment had been treated with tooth sealant 2
years earlier; chromatograms demonstrated
the presence ofbisphenol-A (66.4 fog) and
bisphenol-A dimethacrylate (49.2 jig) in
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Figure 7. Accumulation of (A) pS2 and (B) cathepsin-D in culture medium. MCF7 cells were grown in 10%
charcoal dextran-treated human serum-supplemented medium and exposed for 144 hr to 1 and 10 nM
estradiol-17B. Parallel cultures were exposed to 1 and 10 pM bisphenol-A or bisphenol-A dimethacrylate.
Controls received the vehicle alone. *Values significantly differentfrom control, p <0.001.
her saliva before the second treatment. The
results from this subject were excluded
from analysis.
Samples containing the highest
amounts of bisphenol-A and bisphenol-A
dimethacrylate were estrogenic in the pro-
liferation test. Figure 10 shows the prolifer-
ative pattern of a sample containing 231 jig
bisphenol-A in 27 ml of collected saliva
plus 10 ml ofethanol. An aliquot of 100 pi
ofthis sample diluted in 1 ml ofthe culture
medium was positive in the estrogenicity
assay. The estimated amount ofbisphenol-
A assayed was 0.62 pg/ml. Because the
presence of endogenous estrogens could
not be ruled out, saliva samples taken
before the sealant was applied were also
assayed; none showed estrogenicity.
Discussion
Epoxy resins of the bisphenol-A type have
many applications such as lacquer coating
in food cans, in dental, surgical, and pros-
thetic devices, and as additives in a variety
of other plastic materials (27). Here we
demonstrate that bisphenol-A and bisphe-
nol-A dimethacrylate, components of com-
mercial resin-based composites and sealants
used in dentistry, are estrogenic and may
represent additional sources of human
exposure to xenoestrogens.
Commercial smooth-surface compos-
ites vary in monomer composition and
thus have different physical properties and
biological behaviors. We found that the
amount of bisphenol-A and bisphenol-A
dimethacrylate varied between commercial
* Estradiol-173 A Bisphenol-A
* BADGE dimethacrylate
* Bisphsnol-A U Bis-GMA
100
m
c
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Figure 9. Chromatogram of a saliva sample with
estrogenic activity. Peaks detected at retention
times 2.3, 7.4, 8.5, and 11.9 min were identified as 1)
bisphenol-A, 2) BADGE, 3) bis-GMA, and 4) bisphe-
nol-A dimethacrylate, respectively.
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Figure 8. Competitive displacement of [3H1-estradi-
ol from the estrogen receptor by estradiol-17 and
bisphenol-A, bisphenol-A dimethacrylate, BADGE,
and bis-GMA. The relative binding affinities of
bisphenol-A and bisphenol-A dimethacrylate were
0.012 and 0.0033, respectively. [3H]Estradiol con-
centration was 3 nM, and the total binding was 73
fmol/mg protein; Kd = 8.5x1011 M.
composites and batches. Bisphenol-A was
identified in all the composite samples and
batches analyzed, whereas methacrylate of
bisphenol-A was identified only in the
sealant. The oligomers BADGE and bis-
GMA were found in all three composites
and in the sealant. The proportion ofthese
compounds varied widely between com-
posites and batches. Vankerckhoven et al.
(28) studied 12 commercial restorative bis-
Table 2. Quantitative evaluation of bisphenol-A
identified in saliva obtained 1 hr afterthe applica-
tion of50 mg of sealant
Sample. Bisphenol-Aa
no Sex Volume (ml) (pg) (pg/ml)
1 F 29 320.6 11.1
2 F 31 931.0 30.0
3 F 35 174.6 4.9
4 F 33 865.6 26.2
5 M 26 91.2 3.5
6 M 31 249.6 8.1
7 F 27 165.7 6.1
8 F 38 263.6 6.9
9 M 32 105.3 3.3
10 M 27 230.5 8.5
11 M 36 181.4 5.0
12 M 35 324.2 9.3
13 M 29 353.0 12.2
14 M 39 810.8 20.8
15 M 32 230.8 7.2
16 M 27 130.4 4.8
17 M 27 89.8 3.3
18 F 29 112.4 3.9
"Saliva samples were collected in glass flasks
containing 10 ml ethanol. Values of bisphenol-A
concentration representthose of undiluted saliva.
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Figure 10. Proliferative effect of a saliva sample
obtained 1 hr after treatment with sealant no 1.
Points represent quadruplicate cultures; brackets
indicate SDs. *Values significantly different from
control, p <0.001.
GMA-based resins and found bis-GMA in
all samples at concentrations ranging from
19 to 51% of the total composite weight.
Iso-bis-GMA was also present and repre-
sented 40% of the total percentage ofbis-
GMA. Bisphenol-A dimethacrylate was
found in four commercial mixtures in
amounts that ranged from 6 to 10% ofthe
total composite weight. In addition to
these monomers, other compounds such as
light activators, phthalates, and benzoates,
as well as a large amount of inorganic
fillers, are commom ingredients ofcompos-
ites (28).
Once applied to tooth cavities, compos-
ites and sealants are polymerized in situ.
The degree ofconversion ofoligomers into
polymers varies depending on the composi-
tion of the resin and its distance from the
tooth surface. Conversion of 60-75% is
expected with most common composites
(16), although levels of curing as low as
30% are found in the bottom of fillings.
Lower levels of conversion are thought to
be associated with greater elution of free
components from the composites (16). A
strong inverse relationship has been found
between the leaching of resin from bis-
GMA-based composites and monomer
conversion. Monomer leaching reached a
plateau at conversion levels of60% (29). In
nine commercial resins, the amount of
residual bis-GMA measured at the end of
the setting time was in the range of
0.4-1.2% of the original weight after cur-
ing. Amounts ofthe residual monomers of
up to one-tenth the initial release were
eluted into water over a period of 14 days
(29). Higher values were described by
Ferracane and Condon (16), who found
differences in percentage elution in relation
to curing and double illumination. Our
data confirm these figures: residual bisphe-
nol-A in saliva after curing ranged from 0.1
to 2% ofthe 50 mg initially applied to the
tooth surface in samples taken during 1 hr
after treatment.
In addition to bisphenol-A, present in
100% of the saliva samples, its methacry-
late derivative was present in 3 out of 18
samples. Both compounds were identified
by chromatography and estrogenic activity
as measured in the MCF7 breast cancer cell
proliferation test, the E-screen assay.
The oligomer bis-GMA was not estro-
genic in the E-screen bioassay. Hydrolyzed
BADGE and bis-GMA in alkaline or acidic
media were estrogenic. Chromatographic
analyses ofhydrolyzed samples detected the
presence of bisphenol-A and bisphenol-A
dimethacrylate after treatment. The meta-
bolic routes of systemic degradation of
some composite resins have been studied in
mice (15,19,20). For example, BADGE is
metabolized by oxidative dealkylation to
give a phenol diol derivative. Much atten-
tion has been given to the smaller fragment
of the cleavage process because of the
mutagenic properties of the glycidylalde-
hyde portion. However, the estrogenic
activity of these derivatives has not been
evaluated; their chemical similarity to some
bisphenol-A derivatives with this property
suggests the need for closer examination.
Moreover, little information is available
about the potential estrogenicity of by-
products of the environmental breakdown
ofbiphenolic compounds. Lobos et al. (30)
isolated a novel bacterium from the sludge
ofawastewater treatment plant ofaplastics
manufacturing facility; the organism was
able to degrade bisphenol-A to 4-hydroxy-
benzoic acid and 4-hydroxyacetophenone
(both monophenolic by-products) and to
2,2-bis(4-hydroxyphenyl)-1-propanol, and
finally to 2,3-bis(4-hydroxyphenyl)-1,2-
propanediol. So far, the estrogenicity of
these bisphenol-A derivatives has not been
explored, although the similarity ofthe lat-
ter compound to some stilbenes suggests
that it maydisplay considerable activity.
Bisphenol-A is toxic to fish and inverte-
brates at concentrations of 1.1-10 mg/l ( >
4 pmol/l) (31). In a mouse model, bisphe-
nol-A induced photoallergic contact der-
matitis (32). If administered during
organogenesis, bisphenol-A is fetotoxic
when administered to pregnant mothers. A
study of the effects of bisphenol-A on
reproduction and fertility showed a signifi-
cant reduction in seminal vesicle weight
and sperm motility in treated male mice
(33). These effects were present in parents
and in a second generation when offspring
were maintained at the same exposure level
as their parents (4.37-17.5 mg/kg body
weight). In addition, bisphenol-A treat-
ment resulted in a significant reduction in
the number of litters per pair and in live
pups per litter.
Composites were discovered to be toxic
in humans because lesions developed in
unlined cavities (34,35). The concentra-
tions to which cells and tissues are exposed
in humans are unknown (11), but it was
estimated that seven components of com-
posites, including bisphenol-A, were toxic
in the 10-100 pmol/l concentration range
in an in culture assay (11). The sealant we
tested was toxic to MCF7 breast cancer
cells at concentrations > 50 jig/ml ( -200
pmol/l of bisphenol-A). Lower concentra-
tions were not toxic but were fully estro-
genic in the bioassay (Fig. 1B).
Human exposure to bisphenol-A and
dimethacrylate of bisphenol-A has
increased during the last 30 years because
of the extensive use of bisphenol-A-based
resins. The use of sealants as an effective
therapy and preventive treatment for dental
pits and fissures in adults and children has
been endorsed by European and U.S. agen-
cies (18,36,34). In view ofthe documented
exposure to bis-GMA-based composites
and sealants used in dental treatments for
adults and children, the use ofthese xenoe-
strogens should be reevaluated.
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